Comment
doi: 10.1136/annrheumdis-2018-213027.
Epub 2018 Feb 6.
Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?
Affiliations
- PMID: 29437584
- DOI: 10.1136/annrheumdis-2018-213027
Item in Clipboard
Comment
Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?
Ann Rheum Dis.
2019 Feb.
No abstract available
Keywords: disease activity; rheumatoid arthritis; treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Can we prescribe TMP/SMX prophylaxis without any concerns equally for all patients with rheumatic disease?' by Suyama and Okada.Ann Rheum Dis. 2019 Feb;78(2):e18. doi: 10.1136/annrheumdis-2018-213045. Epub 2018 Feb 6. Ann Rheum Dis. 2019. PMID: 29437583 No abstract available.
Comment on
-
Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.Ann Rheum Dis. 2018 May;77(5):644-649. doi: 10.1136/annrheumdis-2017-211796. Epub 2017 Nov 1. Ann Rheum Dis. 2018. PMID: 29092853 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
